Efficacy of topical pale sulfonated shale oil in the treatment of venous leg ulcers:: A randomized, controlled, multicenter study

被引:12
作者
Beckert, S
Warnecke, J
Zelenkova, H
Kovnerystyy, O
Stege, H
Cholcha, W
Königsrainer, A
Coerper, S
机构
[1] Univ Tubingen Hosp, Dept Gen & Transplantsurg, Tubingen, Germany
[2] Ichthyol Gesell Cordes Hermanni & Co GmbH & Co KG, Hamburg, Germany
[3] DOST Svidnik, Svidnik, Slovakia
[4] Univ Hosp, Dept Dermatol, Dusseldorf, Germany
关键词
D O I
10.1016/j.jvs.2005.09.028
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Venous leg ulcers are a growing socioeconomic burden. Pale sulfonated shale oils (PSSO) are used for therapy of inflammatory skin diseases and have been shown to enhance wound healing in vitro and in vivo. The aim of this study was to investigate whether PSSO is capable of enhancing venous ulcer healing beyond compression therapy alone. Methods. One hundred nineteen patients were enrolled in this randomized, multicenter, observer-blind study. In the treatment group, PSSO 10% was applied daily for 20 weeks, and the control group received the vehicle only. Wounds were covered by a nonadherent gauze dressing, and compression therapy with short-stretch elastic bandages was performed in an outpatient setting. The primary study end point was defined as cumulative reduction in wound area; the secondary study end point was treatment success as assessed by both physicians and patients. Additionally, adverse events, including changes with respect to physical examination and vital signs, were documented. Results. At the end of the study period, ulcer size was significantly more reduced in the PSSO group compared with the vehicle group (15 +/- 15.9 to 6.2 +/- 12.9 cm(2) vs 11.4 +/- 14.5 to 10.8 +/- 15.7 cm(2); P =.0005). The cumulative relative reduction in ulcer area was significantly higher in the PSSO group (-4391 +/- 4748.7 vs -231.9 +/- 6283.6 % X days; P <.0001). Relative reduction in wound area was significantly greater in the PSSO group as early as 6 weeks after the beginning of treatment (-47.4 +/- 28.4 vs -23.8 +/- 42.2%; P <.001). PSSO was judged successful both by physicians and patients. There were no significant differences in adverse events (PSSO, 9 [12.2%]; vehicle, 7 [11.1%]. Similarly, tolerability of PSSO was equal to the tolerability of the vehicle. Conclusion: Pale sulfonated shale oils were capable of favoring venous ulcer healing in addition to compression therapy. PSSO should be considered for future wound care protocols for treatment of venous leg ulcers.
引用
收藏
页码:94 / 100
页数:7
相关论文
共 34 条
  • [1] Belcaro G, 1989, PHLEBOLOGY, V4, P91, DOI [10.1177/026835558900400207, DOI 10.1177/026835558900400207]
  • [2] SUSTAINED COMPRESSION AND HEALING OF CHRONIC VENOUS ULCERS
    BLAIR, SD
    WRIGHT, DDI
    BACKHOUSE, CM
    RIDDLE, E
    MCCOLLUM, CN
    [J]. BRITISH MEDICAL JOURNAL, 1988, 297 (6657) : 1159 - 1161
  • [3] Efficacy of modern dressings in the treatment of leg ulcers:: A systematic review
    Bouza, C
    Muñoz, A
    Amate, JM
    [J]. WOUND REPAIR AND REGENERATION, 2005, 13 (03) : 218 - 229
  • [4] BRIGGS M, 2000, COCHRANE DB SYST REV, V2
  • [5] CHOLCHA W, 1994, ARZNEIMITTEL-FORSCH, V44-1, P170
  • [6] Documentation of 7051 chronic wounds using a new computerized system within a network of wound care centers
    Coerper, S
    Wicke, C
    Pfeffer, F
    Köveker, G
    Becker, HD
    [J]. ARCHIVES OF SURGERY, 2004, 139 (03) : 251 - 258
  • [7] INHIBITORY EFFECTS OF SHALE OILS (ICHTHYOLS) ON THE SECRETION OF CHEMOTACTIC LEUKOTRIENES FROM HUMAN-LEUKOCYTES AND ON LEUKOCYTE MIGRATION
    CZARNETZKI, BM
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1986, 87 (06) : 694 - 697
  • [8] Bacteria and wound healing
    Edwards, R
    Harding, KG
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (02) : 91 - 96
  • [9] ENGST R, 2001, PRAKTISCHE DERMATOLO, V7, P1
  • [10] A bilayered living skin construct (APLIGRAF®) accelerates complete closure of hard-to-heal venous ulcers
    Falanga, V
    Sabolinski, M
    [J]. WOUND REPAIR AND REGENERATION, 1999, 7 (04) : 201 - 207